The MRNA Cancer Vaccines and Therapeutics Market in 2023 is US$ 64.46 billion, and is expected to reach US$ 229.77 billion by 2031 at a CAGR of 17.22%.
FutureWise Research published a report that analyzes MRNA Cancer Vaccines and Therapeutics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the...
Roots Analysis has done a detailed study on “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
§ With over 195 candidates under development, mRNA therapeutics and mRNA Vaccines Market currently represents one of the fastest...
According to IMARC Group’s latest report, titled “mRNA Vaccines and Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.2 Billion by 2028, exhibiting a growth rate (CAGR)...
mRNA vaccines include genetic material in the form of mRNA that tells cells how to make a particular protein. Since mRNA vaccines don't include live viruses, they are not contagious, in contrast to conventional vaccinations that use weakened or inactivated pathogens. The rapid reaction of mRNA vaccines to the COVID-19 pandemic highlights their noteworthy faster development rate...